166
166
Apr 11, 2014
04/14
by
CNBC
tv
eye 166
favorite 0
quote 1
you're on. >> is bristol myers a good investment? >> all right, bristol keeps going down.say don't you love bristol-myers, this became one of the most expensive of the drug companies now it is getting cheap again. it almost yields 3%. when it yields more than 3% we pull the trigger. you know i think the stokt market when you invest wisely is the key to financial freedom. and i always say it has something for everyone no matter what your budget is. you know i got the stocks for it and next up, you shouldn't be buying any stock until you know the answer to this question. stay with cramer. >> every week we focus on the basics, why, because almost nobody tries to teach this stuff. every high school teacher has to sit through a health class where they teach you not to get std's. you can get a graduate degree without learning how to balance a checkbook. that drives me nuts. money is really important. there are few things that can ruin a relationship or ruin your life faster than money troubles and that's why i'm running these play book segments i know you like so much. week afte
you're on. >> is bristol myers a good investment? >> all right, bristol keeps going down.say don't you love bristol-myers, this became one of the most expensive of the drug companies now it is getting cheap again. it almost yields 3%. when it yields more than 3% we pull the trigger. you know i think the stokt market when you invest wisely is the key to financial freedom. and i always say it has something for everyone no matter what your budget is. you know i got the stocks for it...
265
265
Apr 11, 2014
04/14
by
KICU
tv
eye 265
favorite 0
quote 0
gilead shares plunged 7%,merck lost 2% as did bristol myers. cancellations soared in the airline industry as winter weather tripped-up flights. on-time arrival rates collectively fell to 78.4 percent in 2013, down from 81.8 percent the prior year, according to a report from the department of transportation. only 70% of flights were one time last month. the 3rd lowest in 19 years. americans who are married, older and female tend to get the best rates on car insurance. but even for drivers who don't fall into those categories laura admas of insurance quotes.com says it's still possible to steer toward a discount. there are some things we can't control like our age and our gender. but even if you can't control those things that doesn't mean that you won't qualify for other types of savings and discounts. so be proactive, talk to your insurance company and find out how to save money. and of course shop around, each year to make sure there isn't a better deal out there that you're missing." adams says students, and younger married couples are the mo
gilead shares plunged 7%,merck lost 2% as did bristol myers. cancellations soared in the airline industry as winter weather tripped-up flights. on-time arrival rates collectively fell to 78.4 percent in 2013, down from 81.8 percent the prior year, according to a report from the department of transportation. only 70% of flights were one time last month. the 3rd lowest in 19 years. americans who are married, older and female tend to get the best rates on car insurance. but even for drivers who...
175
175
Apr 21, 2014
04/14
by
MSNBCW
tv
eye 175
favorite 0
quote 0
in exchange, christie didn't file charges against bristol-myers squib.t to his alma mater originallied with the company and not with him. ombudsman hobbs insists he'll have complete authority to address ethical issues. ethical issues that maybe the fact the law firm hired by christie donated $10,000 in the governor's association in the days right before the report clearing christie was released. $10,000 march 18th. that law firm gibbs and dunn said they regularly donate to the rga and have done so since 2009. christie is busy carrying out the recommendations to fix his troubled administration. also on thursday, christie eliminated the department that had, according to the review, doled out political rewards and punishments to mayors across the state. the office once held by campaign manager bill stepien and former deputy of staff bridget anne kelly. familiar names. stepien and among those who did not talk to lawyers. as early as this week as it calls its first witness in for testimony. joining me now is democratic assemblyman john wisniewski. i'm excited
in exchange, christie didn't file charges against bristol-myers squib.t to his alma mater originallied with the company and not with him. ombudsman hobbs insists he'll have complete authority to address ethical issues. ethical issues that maybe the fact the law firm hired by christie donated $10,000 in the governor's association in the days right before the report clearing christie was released. $10,000 march 18th. that law firm gibbs and dunn said they regularly donate to the rga and have done...
98
98
Apr 30, 2014
04/14
by
KQEH
tv
eye 98
favorite 0
quote 0
bristol myers helped by cost cuts and lower taxes. t revenues, missed estimates and shares fell on concerns over a possible delay in completing the marketing application for the high-profile cancer drug. bristol fell to 49.32. >>> and biggest u.s. tire maker hurt by severe weather in north america. and a labor dispute in venezuela also took a $132 million charge related to a drop in the value of venezuela's currency. shares fell 7 and a half percent to $25.11. ibm's board improved a 16% increase in the quarterly dividend which is now $1.10 a share. paid to stockholders in june. this is the 19th year in a row that the company will up the return. shares up 1% to $195.11. >>> the stock market is doing better since the financial crisis but is taking a bit longer for america's retirement prospects to get back on track. the nation's largest provider of retirement plans revealed today some positive results for millions of americans in the five years since the market downturn. but there is still plenty of room for improvement. >>> a surging st
bristol myers helped by cost cuts and lower taxes. t revenues, missed estimates and shares fell on concerns over a possible delay in completing the marketing application for the high-profile cancer drug. bristol fell to 49.32. >>> and biggest u.s. tire maker hurt by severe weather in north america. and a labor dispute in venezuela also took a $132 million charge related to a drop in the value of venezuela's currency. shares fell 7 and a half percent to $25.11. ibm's board improved a...
SFGTV: San Francisco Government Television
23
23
Apr 3, 2014
04/14
by
SFGTV
tv
eye 23
favorite 0
quote 0
design process, we determined that the only way to provide an a-d-a accessible path is to build a bristol-myers squibbv bridge that actually goes out over the water. that was an unforeseen event driven primarily because there is a puc force main underneath the path we didn't know about ~. our original path included redesigning that force main. so, that is basically what's driving the budget shortfall on this project. that would be solved by the supplemental. the [speaker not understood] design for tulare park is shown by the bridge and enhancement of landscaping across. the creek is bayview gateway. this used to be part of the port's working waterfront. today it's just an asphalt lot and brick building you see there is a fire station which would not be impacted by our project. what we propose to do is remove a lot of the wharf, open up the waterfront, restore the shoreline, and provide a pedestrian access and public amenities [speaker not understood], benches, things like that. here's the conception design. you can sort of see public pathways. >> can you talk into the microphone? thanks. >> sor
design process, we determined that the only way to provide an a-d-a accessible path is to build a bristol-myers squibbv bridge that actually goes out over the water. that was an unforeseen event driven primarily because there is a puc force main underneath the path we didn't know about ~. our original path included redesigning that force main. so, that is basically what's driving the budget shortfall on this project. that would be solved by the supplemental. the [speaker not understood] design...
88
88
Apr 29, 2014
04/14
by
CNBC
tv
eye 88
favorite 0
quote 0
number 15 on the list later this hour. >>> earnings central heating up today, drugmakers merck, bristol-myersmorning. forest labs ceo will be talking to us first on cnbc later in the show. after the bell, ebay and twitter will be capping off the day. meantime in washington, the federal reserve kicking off a two-day meeting, leading to an announcement on wednesday after noon. this sun with of the meetings that does not come with a news conference. check out the markets right now. yesterday we did see a mixed day for the markets. the dow was up by about 87
number 15 on the list later this hour. >>> earnings central heating up today, drugmakers merck, bristol-myersmorning. forest labs ceo will be talking to us first on cnbc later in the show. after the bell, ebay and twitter will be capping off the day. meantime in washington, the federal reserve kicking off a two-day meeting, leading to an announcement on wednesday after noon. this sun with of the meetings that does not come with a news conference. check out the markets right now....
127
127
Apr 2, 2014
04/14
by
CNBC
tv
eye 127
favorite 0
quote 0
of whiting, we'll talk about a portfolio that needs, indeed -- you thought i was going to say bristol-myerslgene. ♪ hallelujah let's go to howard in california. howard? >> caller: hello, mr. cramer! let me give you a big boo-yah from central california. i would like to know if i'm diversified. isys pharmaceutical, technology, tibco technologies, key corporation and facebook. >> all right. this is going to be very, very tough. key corp., the charitable trust likes it, facebook, same, undervalued on 2016 numbers. here's the problem, tibco, that's tech, i think this portfolio could use a honeywell, an industrial, and it could use a financial. and that's why -- oh, no, key corp., it could use a -- you know what, i want to recommend here, i think we should give it a tech. a -- i want to do a defense stock. itching to give it away. lockheed martin. there, i said it. please come on, lockheed, martin. and that, ladies and gentlemen is the conclusion of "am i diversified." diversified." ♪ [ girl ] my mom, she makes underwater fans that are powered by the moon. ♪ she can print amazing things, right f
of whiting, we'll talk about a portfolio that needs, indeed -- you thought i was going to say bristol-myerslgene. ♪ hallelujah let's go to howard in california. howard? >> caller: hello, mr. cramer! let me give you a big boo-yah from central california. i would like to know if i'm diversified. isys pharmaceutical, technology, tibco technologies, key corporation and facebook. >> all right. this is going to be very, very tough. key corp., the charitable trust likes it, facebook,...
45
45
Apr 15, 2014
04/14
by
CNBC
tv
eye 45
favorite 0
quote 0
. >> for two and a half years or more, i have owned stocks like merck, lily, pfizer, bristol-myers, youand i continue to like these names better because, yes, i'm not getting as much of the volatility and some of the spikes you see in the other name, but they're outperforming. you can lay on strategies. plus 2.5%, 3%. >> pete, what about the valuation -- >> we've got to do. >> but the forward p/es, they're very nice. are 12 to 16 p/es on most of the big companies. >> all right. we've got to do. we're coming back. mike mayo last month joined the half, he was fire up about citi. >> who will be held accountable at citigroup? >> that's not all he said, and with the bank's first quarter in the books and no major sea sweep changes, what does mike mayo think now? you'll hear from him next. to relieve my pain. this is humira helping me lay the groundwork. this is humira helping to protect my joints from further damage. doctors have been prescribing humira for ten years. humira works by targeting and helping to block a specific source of inflammation that contributes to ra symptoms. humira is pr
. >> for two and a half years or more, i have owned stocks like merck, lily, pfizer, bristol-myers, youand i continue to like these names better because, yes, i'm not getting as much of the volatility and some of the spikes you see in the other name, but they're outperforming. you can lay on strategies. plus 2.5%, 3%. >> pete, what about the valuation -- >> we've got to do. >> but the forward p/es, they're very nice. are 12 to 16 p/es on most of the big companies....
37
37
Apr 21, 2014
04/14
by
CSPAN2
tv
eye 37
favorite 0
quote 0
public, academic and private industry labs, taxol was isolated and synthesized and then nih found bristol-myers squibb as a partner to commercialize it. from the 1980s, the purpose was to allow the biotechnology industry to take off and the service exceeded at doing that. we also have other programs i talk about come to provide special predatory favors, financing for companies that may drugs for rare diseases, a whole major profitable subset of the industry. what if it is good be the biggest of all, the human genome product it were seeing patricia maisch medicine before our eyes from conventional therapy gene-based therapy, how to do that? we need a map. a map of the human genome. the nih did not end during the 1990s it developed a map of the genome. since then private companies have isolated specific genes and then i developed developing gene therapy, diagnostic techniques and otherwise of harnessing it. what has nih been? did develop a new center. and 2011 the national center for transitional sciences was launched to explicitly find private companies that would commercialize genomic therapy.
public, academic and private industry labs, taxol was isolated and synthesized and then nih found bristol-myers squibb as a partner to commercialize it. from the 1980s, the purpose was to allow the biotechnology industry to take off and the service exceeded at doing that. we also have other programs i talk about come to provide special predatory favors, financing for companies that may drugs for rare diseases, a whole major profitable subset of the industry. what if it is good be the biggest of...
91
91
Apr 25, 2014
04/14
by
CNBC
tv
eye 91
favorite 0
quote 0
also, ebay and merck, drug giants, like bristol-myers, all on tuesday.things, glaxo smithkline, and western digital, as well. some of the storage companies getting attention among investors' circles, and that will be a big one here. yelp, as well, another big one to watch. on thursday, the oil giants, specifically exxon mobil and conocophilips. conoco phillips, exxon mobil, everyone likes seeing its because we had to be whether upstream results match with what's happening downstream. you have -- so it's a huge day. i mean, i want to do this dance for earns, because there's so many you want to watch. honestly, brian, maybe i want to do a little dance for my earnings and everything, you do not want to see me dance again. >> yeah, we do. >> congratulations on your new internet gif. i expect to see it on twitter any minute now. >> don't lynn to the guys, that hit was a thriller. you couldn't beat it. >> the other network has dancing with stars. we have dancing with black holes on -- >> all right. your next guest is the founder and ceo, a firm with a many 5%
also, ebay and merck, drug giants, like bristol-myers, all on tuesday.things, glaxo smithkline, and western digital, as well. some of the storage companies getting attention among investors' circles, and that will be a big one here. yelp, as well, another big one to watch. on thursday, the oil giants, specifically exxon mobil and conocophilips. conoco phillips, exxon mobil, everyone likes seeing its because we had to be whether upstream results match with what's happening downstream. you have...
246
246
Apr 29, 2014
04/14
by
BLOOMBERG
tv
eye 246
favorite 0
quote 0
pfizer and bristol-myers squibb are down. they have been moving the market.e news, a couple of tech companies we will see after the bell. bothand twitter are reporting earnings. we will give you those numbers as they cross. tiwtt -- twitter up 1.5%. quick break and then erik is back with more. >> we certainly are. >> when we come back, we will share bloomberg's interview with bob iger. >> ceo of the walt disney company. stick around. lots more from the milken conference. ♪ >> live from the milken conference, this is a special edition of ""market makers." >> welcome back. i'm erik schatzker at the milken global conference in beverly hills. >> and i'm stephanie ruhle. a lot more to cover. >> we are going to continue with an old friend. haven't seen him for quite some time. the professor of economic history at harvard university. great to see you. i should remind everybody that you've written all kinds of the selling books. >> that's why i have not been on television. i've been writing books. >> what does the world look like these days? you have written a book c
pfizer and bristol-myers squibb are down. they have been moving the market.e news, a couple of tech companies we will see after the bell. bothand twitter are reporting earnings. we will give you those numbers as they cross. tiwtt -- twitter up 1.5%. quick break and then erik is back with more. >> we certainly are. >> when we come back, we will share bloomberg's interview with bob iger. >> ceo of the walt disney company. stick around. lots more from the milken conference. ♪...
485
485
Apr 7, 2014
04/14
by
BLOOMBERG
tv
eye 485
favorite 0
quote 1
bristol-myers, etc..coming up, arianne huffington joins us to discuss her new book "thrive." >> this is "bloomberg surveillance." i'm scarlet fu with tom keene and adam johnson. our guest host is aaron hurst, the author of the new book "the purpose economy." >> very good. just that simple. futures, negative eight. we start off a little rocky. we got an interesting topic. how about this quote -- focuses -- focusing is about state -- said no. that is according to the and john's. we begin the work we dreading the modern work we put it our digital exhaustion, but -- the path to sobriety may be saying no. i all accounts, arianna huffington is a success. she got there and here by saying no. she joins us in support of "thrive." congratulations in the book. you get peggy lee in the beginning of the book. nasim in as well./ when did your life change? >> my life changed actually seven years ago yesterday. >> i saw that on twitter. >> when i collapsed from exhaustion, burnout, and food deprivation. i hit my head on
bristol-myers, etc..coming up, arianne huffington joins us to discuss her new book "thrive." >> this is "bloomberg surveillance." i'm scarlet fu with tom keene and adam johnson. our guest host is aaron hurst, the author of the new book "the purpose economy." >> very good. just that simple. futures, negative eight. we start off a little rocky. we got an interesting topic. how about this quote -- focuses -- focusing is about state -- said no. that is...
90
90
Apr 28, 2014
04/14
by
BLOOMBERG
tv
eye 90
favorite 0
quote 0
bristol-myers walks away with that. it would rank fourth or fifth.ot necessarily a ridiculous number. still the course value. that is what i think they said they had negotiated in january. i saw some headlines saying the pfizer ceo -- >> they could make an offer for less than 47. we could talk about this forever. thank you both. >> coming up, why you should be watching bp ahead of that company's earnings tomorrow. we will have that story and plenty more for you to watch when we come back after a short break. ♪ >> welcome back. this is "countdown." >> six minutes or so to go until the start of european equity trading. let's look at some of the stocks to watch. we are joined by joshua. so much to talk about. where do you want to start, drugs, capital goods, earnings coming up this week that are picking your interest. >> it is a hugely in terms of data. we have gdp figures in the u.k. and u.s. new line now we have nowpfizer and astra to -- we have got pfizer and astrazeneca. confirmedas been about the interest from pfizer. they are going hostile. 46-61
bristol-myers walks away with that. it would rank fourth or fifth.ot necessarily a ridiculous number. still the course value. that is what i think they said they had negotiated in january. i saw some headlines saying the pfizer ceo -- >> they could make an offer for less than 47. we could talk about this forever. thank you both. >> coming up, why you should be watching bp ahead of that company's earnings tomorrow. we will have that story and plenty more for you to watch when we come...
149
149
Apr 1, 2014
04/14
by
CNBC
tv
eye 149
favorite 0
quote 0
it was $11 billion but they had the formulation, remember, bristol-myers bought a company that thoughtad the formulation and they wrote it off very quickly because there were two fatalities in the test. this is remarkable that you have -- now, these stocks are up huge, so someone says, well, wait a second, ca-ching, ca-ching, celgene up 12%. my charitable trust has been buying celgene. can i tell you what an idiot i feel like? because all i did was look at the valuation. sorry. >> what else are you supposed to look at? >> you are supposed to look at the buzz. it has no buzz. >> shame on you. >> i should have looked at merck, it hasn't had buzz since 1987 and suddenly merck is up. >> it's easily acquired if you have a multibillion drug. it gets you some buzz. >> i think this quarter will be a change in those stocks. a lot of people are telling me they are ready to buy. >> it's under way now. >>> trust in the markets and the fbi when we come back what the agency told cnbc about investigating high frequency trading. >>> also ahead domino's game plan for growth beyond the final four. we'll
it was $11 billion but they had the formulation, remember, bristol-myers bought a company that thoughtad the formulation and they wrote it off very quickly because there were two fatalities in the test. this is remarkable that you have -- now, these stocks are up huge, so someone says, well, wait a second, ca-ching, ca-ching, celgene up 12%. my charitable trust has been buying celgene. can i tell you what an idiot i feel like? because all i did was look at the valuation. sorry. >> what...
102
102
Apr 25, 2014
04/14
by
BLOOMBERG
tv
eye 102
favorite 0
quote 0
will buy a french company or bristol-myers and by a foreign drug company.he next wave of mergers, u.s. companies using foreign cash to buy foreign companies. >> that will help boost profits but does not contribute to jobs recovery at home. >> this is a lost opportunity for americans. we are losing jobs and losing profit with evidence. all this money is going overseas and it is going to stay there because of our stubborn policy in washington. >> you just gave me an idea. u.s. companies with a lot of foreign cash that are potentially going to buy cheap companies abroad -- is industrials? >> are you asking a question for your 12:00 noon show? >> absolutely. >> that is terrible! >> shameless plug. >> we have a global radio audience. >> the radio audience will listen to you until 10:00 and then at :00 they will -- >> timeout. >> is industrials? >> europe has lagged our recovery here. you're going to find some cheaper industrial names there. there is a big caveat that goes back to the russia-ukraine situation. it has to do with the dependency europe as for the oi
will buy a french company or bristol-myers and by a foreign drug company.he next wave of mergers, u.s. companies using foreign cash to buy foreign companies. >> that will help boost profits but does not contribute to jobs recovery at home. >> this is a lost opportunity for americans. we are losing jobs and losing profit with evidence. all this money is going overseas and it is going to stay there because of our stubborn policy in washington. >> you just gave me an idea. u.s....
393
393
Apr 29, 2014
04/14
by
CNBC
tv
eye 393
favorite 0
quote 0
. >>> earnings central heating up today, drugmakers merck, bristol-myers and forest labs all out this morning. forest labs ceo will be talking to us first on cnbc later in the show. after the bell, ebay and twitter will be capping off the day. meantime in washington, the federal reserve kicking off a two-day meeting, leading to an announcement on wednesday after noon. this sun with of the meetings that does not come with a news conference. check out the markets right now. yesterday we did see a mixed day for the markets. the dow was up by about 87 points, the nasdaq down yesterday. this morning you see green arrows across the board. the dow indicated to open up by about 63 points. s&p futures are 8.5 points above fair value and the nasdaq up by more than 22 points. the bond market, the ten-year note is yielding 2.722%. and check out the dow utilities. that index closing at a record high for the first time in six years. it added three points to close at 554. yes. we'll see what happens today. let's get over to andrew right now. he has more of today's top corporate stories. andrew, good
. >>> earnings central heating up today, drugmakers merck, bristol-myers and forest labs all out this morning. forest labs ceo will be talking to us first on cnbc later in the show. after the bell, ebay and twitter will be capping off the day. meantime in washington, the federal reserve kicking off a two-day meeting, leading to an announcement on wednesday after noon. this sun with of the meetings that does not come with a news conference. check out the markets right now. yesterday we...
192
192
Apr 14, 2014
04/14
by
CNBC
tv
eye 192
favorite 0
quote 0
so people recognized that ddd may not be bristol-myers. if we can see strategists stabilize, we see an end of a cessation of ipos. we see twitter do well, periodic soft go down. >> twitter is not going to do well until we see the earnings. >> one of the things that hurt us, hurt the bulls is that there is no earnings of these companies that are. >> it's earnings rorkts i should say. >> it's quarterly ohrt. >> google is inexpensive on the earning, goggle will be the proxy about whether this group does well. don't go crazy until you see the whites of their eyes. you see some of these inflation reports. >> we did get some numbers from citi though. it beat expectation, lowered expenses and fixed income. revenue above consensus, too. in the earnings release, they said result itself were strong despite a quarter difficult to the company. last month city failed higher dividends and stock buy backs. you think you said on friday, the number could be good. for the buy back, for the dividend. stay away. >> that number was good, interest mar jen up tw
so people recognized that ddd may not be bristol-myers. if we can see strategists stabilize, we see an end of a cessation of ipos. we see twitter do well, periodic soft go down. >> twitter is not going to do well until we see the earnings. >> one of the things that hurt us, hurt the bulls is that there is no earnings of these companies that are. >> it's earnings rorkts i should say. >> it's quarterly ohrt. >> google is inexpensive on the earning, goggle will be the...
117
117
Apr 9, 2014
04/14
by
CNBC
tv
eye 117
favorite 0
quote 0
out of bristol-myers, out of eli lilly into the beginning of what i think will be a biotech move.on of biotech ipos coming. you have to be careful. >> hershey off more than 2%. this is going to take you back to basically early february prices as goldman takes it from hold to sell. >> their reasoning is not wrong. they are saying that stock is priced for perfection. it's been a remarkable performer. remember when hershey used to make everything in america and moved their manufacturing offshore and that's where their numbers came from. that's a downgrade that hurts because it had been the bellwether in the group, the one that people said yeah, listenen, this is what happens if you rationale production and take sales up. that hurts. i like pinnacle foods run by a man who came from mars and has been a winner for yield and for price appreciation. >> auto companies, gm, ford, in the red on that downgrade out of morgan stanley. you mentioned they cut the rating on gm and their numbers on ford, although the ford focus out today as the best-selling car of all of 2013. 1, 09,000 focuses. >>
out of bristol-myers, out of eli lilly into the beginning of what i think will be a biotech move.on of biotech ipos coming. you have to be careful. >> hershey off more than 2%. this is going to take you back to basically early february prices as goldman takes it from hold to sell. >> their reasoning is not wrong. they are saying that stock is priced for perfection. it's been a remarkable performer. remember when hershey used to make everything in america and moved their...
235
235
Apr 2, 2014
04/14
by
CNBC
tv
eye 235
favorite 0
quote 0
you do have to be careful of bristol-myers pill that could come in, but right now gilead has the hep-cly to itself. >> which we talked about a good deal yesterday. >> yes. >> that the current therapy's actually less than the existing therapy in terms of price. >> right. >> even though people -- there may be some complaints about that. >> you always find the health insurers, they balk at some of the prices. they know that without these drugs -- these drugs are all priced under -- >> they help something instead of having to treat it forever. >> this is revolutionary and i can understand why the stock is up. celgene up seven points. why celgene up? because it's inexpensive versus pfizer. but, you know, i think that yesterday was one of those perfect days where you had the old and the new go up. people aren't backing away from these industrials. i saw, for instance, the disk drive stocks. have you seen -- remember this -- ideas that people said they wanted to short? >> yes. >> you mean western digs of the world? >> people wanted to short hewlett-packard, short the disk drives companies, sh
you do have to be careful of bristol-myers pill that could come in, but right now gilead has the hep-cly to itself. >> which we talked about a good deal yesterday. >> yes. >> that the current therapy's actually less than the existing therapy in terms of price. >> right. >> even though people -- there may be some complaints about that. >> you always find the health insurers, they balk at some of the prices. they know that without these drugs -- these drugs are...
237
237
Apr 22, 2014
04/14
by
CNBC
tv
eye 237
favorite 0
quote 0
bristol-myers, built itself on a biotech buy buy buy.he biotechs got too big, merging with each other. glaxo has been stuck at 52.53, novartis has not been able to talk their stock up. this is the way to get things going. no longer flat lining they're going. >> with all of that we'll talk more about -- >> they need tax inversions. >> yes. >> we'll talk more about earnings including results from mcdonald's, of course. we'll talk about netflix's numbers last night. how the stock is reacting on both of those fronts and also ahead, david's exclusive with valueact ceo jeff uben. hear what he has to say about buying allergan. we'll find out if today is another turnaround tuesday. more "squawk on the street" in just a minute. just a minute.@@ >>> netflix reporting better than expected first quarter earnings. total up by 4 million in the period. company intends to increase u.s. prices by new subscribers by a dollar or two and expressing opposition of nbc's parent comcast and time warner cable. netflix ceo reed hastings on last night's conference
bristol-myers, built itself on a biotech buy buy buy.he biotechs got too big, merging with each other. glaxo has been stuck at 52.53, novartis has not been able to talk their stock up. this is the way to get things going. no longer flat lining they're going. >> with all of that we'll talk more about -- >> they need tax inversions. >> yes. >> we'll talk more about earnings including results from mcdonald's, of course. we'll talk about netflix's numbers last night. how the...
286
286
Apr 17, 2014
04/14
by
CNBC
tv
eye 286
favorite 0
quote 0
bristol myers 14% growth, 27 p/e. chipotle, later, 22% growth, 44 p/e. pane panera.his is an algebra question. if you guess 19% growth, how can you not pay well at least 30 times earnings? coca-cola here -- coca-cola has 6.7, pepsi claiming 7, and coca-cola sales at the same p/e as google. how is that possible? google is going higher. i said it. >> multiple of google is going much higher. >> in the next two weeks. my travel trust tried to buy some last night. it's going much higher. extraordinary quarter. the analysts don't know how to analyze it. this will be the quarter, by the way, they are going to get you, mark my words, they are going to get you more dollars per ad on a mobile phone than they are desk top. this was the quarter. he basically said listen, guys, everyone wants it on their cell phone. get the 5.1, 5.6 inch factor, everyone wants their cell phone and if they want it, google will control it. i would just buy it. just buy it. >> on ibm, guys, 2.54 was in line lower than expected tax rate, obviously lower share count, that's going to take 50 points off
bristol myers 14% growth, 27 p/e. chipotle, later, 22% growth, 44 p/e. pane panera.his is an algebra question. if you guess 19% growth, how can you not pay well at least 30 times earnings? coca-cola here -- coca-cola has 6.7, pepsi claiming 7, and coca-cola sales at the same p/e as google. how is that possible? google is going higher. i said it. >> multiple of google is going much higher. >> in the next two weeks. my travel trust tried to buy some last night. it's going much higher....